Bausch+Lomb Results Presentation Deck

Growth Momentum in Durable Consumer Portfolio BAUSCH LOME VER LUMIFY EYE ILLUMINATIONS V-INT MICULA Cleansing Water Era Malaup Remova MARCH CLINICALLY PROVEN BRUSCH+LOND LUMIFY E LUMINATION BAUSCH + LOMB TICHEAVE distsing WH MISCELLOW BAUSCE LOME LUMIFY ORINOND NE TARTRATE 8PH HALMK SLUI IN CEZAN Worksin 1 minuta Lasts up to 0 hours Sel 008 FL 02 12.5 mL LUNIFY FYE ILLUMINATIONS $140M + Revenue Franchise¹ LUMIFY FINESTRES BAUSCH + LOMB LUMIFY EYE ILLUMINATIONS Lash & Brow Sanum MAIN POTEN BAUSCH LOMB LUMIFY EYE ILLUMINATIONS|||||||||||||||| 108-11 Brightening Lye Droom C COMICALLY PROVEN +23% Reported Growth Strong U.S. Consumption Growth, Successful Launch in Canada Expanding Franchise into New Geographies and Adjacent Categories BAUSCH & LOMB PreserVision™ SUPPLEMENT AREDS 2 NEW! CoQ10 2 Health Benefits in 1 Formula 80 DAY Artelac A Rebalance de ogledo BAUSCHOLOME 1. Twelve months ended 6/30/23 2. Constant currency. This is a non-GAAP measure or ratio. See Slide 1 and Appendix for further information on non-GAAP measures and ratios. ALONE PreserVision ALT Artelec Rebalance AREDS www.t Eye Vitamins (+11% reported; +12% cc²) Continuing To Expand Franchise With Launch of CoQ10 and OCUsorb Artelac 1ml Augentropfen enthak 3,20 mg Hypromelose 10m Augentropfen BAUSCH+LOMB Artelac BAUSCH & LOMB Ocuvite Hotel ADULT 50+ HELPS PROTECT EYE HEALTH VITAMIN D Artelac Complete MDO Artelac® (+24% reported; +24% cc²) Launched in >35 Countries, Growth in European Markets Expanded Portfolio with Acquisition of Blink® Eye Drops LArtelac 18

View entire presentation